Literature DB >> 29655379

Shigella infection in children under 5 years old in western French Guiana.

M Parisot1, N Parez1, R Boukhari2, S Breurec3, A Jolivet4.   

Abstract

French Guiana, a tropical country, is characterised by a young and multi-ethnic population. Difficulties in accessing safe water sources lead to outbreaks of gastroenteritis. The objectives of this study were (1) to describe the microbiological profile of shigella strains isolated in western French Guiana, including antimicrobial susceptibility and the distribution of strains in terms of species and serotypes and (2) to estimate the incidence of shigellosis in children under 5 years old. A retrospective observational study was conducted of 213 cases of shigellosis diagnosed in the biology department of the hospital centre for western French Guiana between 2000 and 2012 in children under 5 years old. The serogroups (formerly known as species) that predominates in French Guiana was Shigella flexneri. No resistance was observed to fluoroquinolones or to third-generation cephalosporins. The average incidence of shigellosis in children under 5 years old in western French Guiana was estimated at 189.6 cases per 100 000 inhabitants per year. Shigellosis is a public health problem in western French Guiana. These infections suggest the difficulties in accessing safe water sources and the lack of public sanitation. A quadrivalent vaccine containing Shigella sonnei and three serotypes of S. flexneri (S. flexneri 2a, 3a and 6) could provide broad coverage against shigella infections.

Entities:  

Keywords:  Antibiotic resistance; diarrhoea; dysentery (bacillary); epidemiology; shigella

Mesh:

Substances:

Year:  2018        PMID: 29655379      PMCID: PMC9184929          DOI: 10.1017/S0950268818000912

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  25 in total

1.  Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.

Authors:  S K Niyogi
Journal:  Clin Microbiol Infect       Date:  2007-10-22       Impact factor: 8.067

2.  Protective role of human lactoferrin against invasion of Shigella flexneri M90T.

Authors:  H F Gomez; I Herrera-Insua; M M Siddiqui; V A Diaz-Gonzalez; E Caceres; D S Newburg; T G Cleary
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

Review 3.  Enteric infections and the vaccines to counter them: future directions.

Authors:  Myron M Levine
Journal:  Vaccine       Date:  2006-03-24       Impact factor: 3.641

4.  Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.

Authors:  Nahid Farzam; Reut Ramon-Saraf; Yonit Banet-Levi; Liat Lerner-Geva; Shai Ashkenazi; Joanna Kubler-Kielb; Evgeny Vinogradov; John B Robbins; Rachel Schneerson
Journal:  Vaccine       Date:  2017-08-07       Impact factor: 3.641

5.  Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED).

Authors:  James A Platts-Mills; Sudhir Babji; Ladaporn Bodhidatta; Jean Gratz; Rashidul Haque; Alexandre Havt; Benjamin Jj McCormick; Monica McGrath; Maribel Paredes Olortegui; Amidou Samie; Sadia Shakoor; Dinesh Mondal; Ila Fn Lima; Dinesh Hariraju; Bishnu B Rayamajhi; Shahida Qureshi; Furqan Kabir; Pablo P Yori; Brenda Mufamadi; Caroline Amour; J Daniel Carreon; Stephanie A Richard; Dennis Lang; Pascal Bessong; Esto Mduma; Tahmeed Ahmed; Aldo Aam Lima; Carl J Mason; Anita Km Zaidi; Zulfiqar A Bhutta; Margaret Kosek; Richard L Guerrant; Michael Gottlieb; Mark Miller; Gagandeep Kang; Eric R Houpt
Journal:  Lancet Glob Health       Date:  2015-07-19       Impact factor: 26.763

6.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

Review 7.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

8.  Use of population-based surveillance to define the high incidence of shigellosis in an urban slum in Nairobi, Kenya.

Authors:  Henry N Njuguna; Leonard Cosmas; John Williamson; Dhillon Nyachieo; Beatrice Olack; John B Ochieng; Newton Wamola; Joseph O Oundo; Daniel R Feikin; Eric D Mintz; Robert F Breiman
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  Shigella in Brazilian children with acute diarrhoea: prevalence, antimicrobial resistance and virulence genes.

Authors:  Mireille Ângela Bernardes Sousa; Edilberto Nogueira Mendes; Guilherme Birchal Collares; Luciano Amedée Péret-Filho; Francisco José Penna; Paula Prazeres Magalhães
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

10.  Etiology and Epidemiology of Diarrhea in Hospitalized Children from Low Income Country: A Matched Case-Control Study in Central African Republic.

Authors:  Sébastien Breurec; Noémie Vanel; Petulla Bata; Loïc Chartier; Alain Farra; Loïc Favennec; Thierry Franck; Tamara Giles-Vernick; Jean-Chrysostome Gody; Liem Binh Luong Nguyen; Manuella Onambélé; Clotaire Rafaï; Romy Razakandrainibe; Laura Tondeur; Vianney Tricou; Philippe Sansonetti; Muriel Vray
Journal:  PLoS Negl Trop Dis       Date:  2016-01-05
View more
  2 in total

Review 1.  Roles of Shiga Toxins in Immunopathology.

Authors:  Moo-Seung Lee; Vernon L Tesh
Journal:  Toxins (Basel)       Date:  2019-04-09       Impact factor: 4.546

Review 2.  Escherichia coli Shiga Toxins and Gut Microbiota Interactions.

Authors:  Kyung-Soo Lee; Yu-Jin Jeong; Moo-Seung Lee
Journal:  Toxins (Basel)       Date:  2021-06-11       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.